Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-12-032980)

Filing Details

Accession Number:: 0001127602-12-032980
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-12-05 17:06:14
Reporting Period:: 2012-12-03

Filing Date:: 2012-12-05
Accepted Time:: 2012-12-05 17:06:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
794172	Meridian Bioscience Inc	VIVO	In Vitro & In Vivo Diagnostic Substances (2835)	310888197

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1224664	Lawrence Baldini	3471 River Hills Drive Cincinnati OH 45244	Exec Vp, Operations & Is	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-12-03	32,500	$20.00	37,500	No	4	S	Direct
Common Stock	Acquisiton	2012-12-04	32,500	$20.07	70,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	P	Direct

Footnotes

The reporting person effected these transactions for tax planning purposes.
The reporting person effected these transactions for tax planning purposes.
Prices range from $20.05 per share to $20.12 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.